KPTI
Companies
NASDAQ
Karyopharm Therapeutics Inc.
Health Care
$4.44
-$5.70 (-56.21%)
Price Chart
Overview
About KPTI
karyopharm therapeutics inc. is a clinical-stage pharmaceutical company focused on discovery and development of novel first-in-class drugs directed against nuclear transport targets for the treatment of cancer and other major diseases. for more information, please visit www.karyopharm.com
Market Cap
$119.7M
Volume
360.0K
Avg. Volume
395.6K
P/E Ratio
-7.260564
Dividend Yield
0.00%
Employees
415.0
Company Information
Risk & Correlation Analysis
Market Correlation
2.09
High Correlation
Volatility
High (0.91)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
High Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Medium Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, KPTI shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$119.7M
Volume360.0K
P/E Ratio-7.26
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 13, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025